Allogeneic stem cell transplant with ATG, high-dose melphalan, and fludarabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic stem cell transplant with ATG, high-dose melphalan, and fludarabine, covering 2014-11-24 to 2014-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer [Phase 2]